Reaching for ‘immorbidity’
“Please governments, keep on investing in basic science”, Paul Stoffels, Chief Science Officer of Johnson & Johnson, implored at the inaugural symposium of the Janssen Prevention Center (JPC) of Janssen Pharmaceutical Companies. The new research centre was established early 2015 and organised its first symposium titled “Reaching for immorbidity” on June 4th at the EYE Film Institute in Amsterdam. Continue reading